CFO of Dicerna Pharmaceuticals Inc (30-Year Financial, Insider Trades) John B Green (insider trades) sold 25,624 shares of DRNA on 04/20/2020 at an average price of $22.95 a share. The total sale was $588,071.
Dicerna Pharmaceuticals Inc is a biopharmaceutical company. It develops ribonucleic acid interference-based pharmaceuticals for treating diseases involving liver, including rare, chronic liver, cardiovascular and viral infections. Dicerna Pharmaceuticals Inc has a market cap of $1.54 billion; its shares were traded at around $20.90 with and P/S ratio of 59.70. Dicerna Pharmaceuticals Inc had annual average EBITDA growth of 12.40% over the past five years. GuruFocus has detected 3 severe warning signs with Dicerna Pharmaceuticals Inc. .
CFO Recent Trades:
- CFO John B Green sold 25,624 shares of DRNA stock on 04/20/2020 at the average price of $22.95. The price of the stock has decreased by 8.93% since.
- CFO John B Green sold 20,469 shares of DRNA stock on 04/07/2020 at the average price of $19.95. The price of the stock has increased by 4.76% since.
Directors and Officers Recent Trades:
- See Remarks Bob D Brown sold 21,466 shares of DRNA stock on 04/20/2020 at the average price of $22.31. The price of the stock has decreased by 6.32% since.
- COO & EVP James B Weissman sold 4,360 shares of DRNA stock on 04/13/2020 at the average price of $20.2. The price of the stock has increased by 3.47% since.
For the complete insider trading history of DRNA, click here
.
